Clinical Trials Directory

Trials / Terminated

TerminatedNCT02373800

Elastography for Evaluating Cervical Maturity in Preparation for Labor Induction at 37 to 42 Weeks of Gestation

Status
Terminated
Phase
Study type
Observational
Enrollment
95 (actual)
Sponsor
Centre Hospitalier Universitaire de Nīmes · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary objective of this study is to determine if a cervical hardness score (determined by cervical ultrasound with elastography) can predict delivery mode (vaginal versus cesarian for slow dilatation (more than 2-3h without fetal suffering) regardless of the induction mode (ocytocin alone or with an intravaginal device releasing PGE2).

Detailed description

The secondary objectives of this study are: A. To determine composite criteria (combining elastographic, parity and Bishop score information) that predict delivery mode. B. To determine the prognostic value of elastography as concerns delivery within 24 hours among patients induced via oxytocin with an intravaginal device releasing PGE2 (Bishop score \< 6). C. To determine the prognostic value of elastography as concerns delivery mode (vaginal versus cesarian for slow dilatation (more than 2-3h without fetal suffering))among patients induced via oxytocin alone. D. To evaluate the intra- and inter-operator reproducibility of the cervical hardness score determined via elastography. E. To evaluate the economic impact of using the cervical hardness score from the point of view of the French social system (French health insurance) and the hospital.

Conditions

Interventions

TypeNameDescription
DEVICECervical ultrasound with elastographyFollowing routine vaginal exam with determination of Bishop's score, cervical ultrasound with elastography will be used to determine a cervical hardness score varying from 1 to 10. Patients are then hospitalized and labor induced 12 to 48 hours after the elastography.

Timeline

Start date
2016-02-04
Primary completion
2018-09-01
Completion
2018-09-01
First posted
2015-02-27
Last updated
2019-01-11

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02373800. Inclusion in this directory is not an endorsement.